# Varenicline For Smokers In Recovery From Alcohol Dependence

> **NCT01092702** · PHASE2,PHASE3 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 32 (actual)

## Conditions studied

- Tobacco Abstinence

## Interventions

- **DRUG:** Varenicline

## Key facts

- **NCT ID:** NCT01092702
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2008-09
- **Final completion:** 2009-09
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2023-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01092702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01092702, "Varenicline For Smokers In Recovery From Alcohol Dependence". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01092702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*